All expected pathogenic variants detected inBRCA1/2were reviewed for evidence of a founder effect. This was carried out by manual review of each expected pathogenic variant by a genetic counselor (E.R.S.) in the Human Gene Mutation Database [27], ClinVar, and PubMed utilizing the currently...